[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2000055348A1 - Sunscreen composition - Google Patents

Sunscreen composition Download PDF

Info

Publication number
WO2000055348A1
WO2000055348A1 PCT/EP2000/001645 EP0001645W WO0055348A1 WO 2000055348 A1 WO2000055348 A1 WO 2000055348A1 EP 0001645 W EP0001645 W EP 0001645W WO 0055348 A1 WO0055348 A1 WO 0055348A1
Authority
WO
WIPO (PCT)
Prior art keywords
peptide
protein
soluble
melanin
composition
Prior art date
Application number
PCT/EP2000/001645
Other languages
French (fr)
Inventor
Indu Mani
Govindarajan Raman
Vandana Sharma
Original Assignee
Unilever Plc
Unilever Nv
Hindustan Lever Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN193BO1999 external-priority patent/IN191336B/en
Priority claimed from GBGB9910274.1A external-priority patent/GB9910274D0/en
Application filed by Unilever Plc, Unilever Nv, Hindustan Lever Limited filed Critical Unilever Plc
Priority to AU29160/00A priority Critical patent/AU2916000A/en
Publication of WO2000055348A1 publication Critical patent/WO2000055348A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/42Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/47Addition of dyes or pigments, e.g. in combination with optical brighteners using synthetic organic dyes or pigments not covered by groups A23L5/43 - A23L5/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Definitions

  • the present invention relates to a process of producing melanin polymers in soluble form and to compositions including such polymers for providing sunscreen benefits by preventing the damaging effects of ultra-violet light on skin.
  • UV light ultra-violet
  • photo-damage The treatment of human skin damaged through exposure to ultra-violet (UV) light, i.e. photo-damage, has been subject to much research effort in recent years, particularly with the realisation that skin cancer and other skin disorders can arise where the exposure to sunlight is excessive.
  • the sensitivity of the human skin to UV exposure is dependent on the amount of the pigment melanin present in the skin.
  • sunscreens act by deflecting and scattering the incident light that produces burning and tanning of the skin or by absorbing this light.
  • the skin has to be protected broadly across the UV range of about 320-400 nm. It is known that careful selection of sunscreens can offer this protection to the skin and reduce the darkening and damaging effects of the radiation.
  • WO 96/25920 (Yale University) , describes the use of melanin polymers in cosmetic compositions for providing a substantive, natural appearing tan and to protect the skin from harmful effects of ultraviolet radiation. Since melanins absorb light throughout the ultraviolet and visible spectra, solubilised melanins are also be effective as glass or plastic tinting agents for eye glasses, contact lenses, car windows, house windows, office buildings etc. Apart from cosmetic benefits, soluble melanins can also be used as colouring agents in coffee, tea, soda, whiskey and other liquors .
  • WO 92/16189 disclose compositions and methods for preparing soluble melanins stable at physiological pH and temperature.
  • the method comprises reacting dopachrome and one or more enzymes derived from biological cells or tissues which have a pigmentary system.
  • the melanin produced is soluble in an aqueous solution at a pH of at least 5 to 9 at a temperature of 0 to 100°C.
  • the melanin formed therein is soluble in an aqueous solution at pH 2 to 11 and temperature 0°C to 50°C.
  • compositions comprising such melanin useful for colouring and or flavouring foodstuffs such as coffee, tea, soda and other beverages .
  • a process for preparing protein- and/or peptide- bound melanin which is soluble in an aqueous solution at pH 2 to 11 and temperature 0°C to 50°C, comprising the steps of reacting dihydroxyphenylalanine with an oxidant enzyme in the presence of an acidic protein and/or peptide having a pi of 3-6.
  • the reaction mixture may optionally additionally comprise one or more of the following: Dihydroxyindole, 5,6 dihydroxyindole-2-carboxylic acid, dopachrome, indole-5,6- quinone and/or melanochrome.
  • the enzyme is a naturally occurring oxidant enzyme such as a tyrosinase.
  • the enzyme source could be either mushroom or neurospora crassa or other natural sources .
  • the dihydroxyphenylalanine (DOPA) is preferably DL- or L- DOPA.
  • the proteins used should preferably have a molecular weight of at least 45,000 Da and a pi of 3 to 6. Suitable proteins include Bovine Serum Albumin and Ovalbumin for example.
  • the concentration of protein used may be 1 ⁇ M to ImM and is preferably 10-100 ⁇ M.
  • the reaction mixture preferably contains DOPA, oxidant enzyme and the acidic protein/peptide in the ratio of 1 : 0.2-0.4 : 0.6-1.2.
  • Metal ions such as copper, zinc and iron may also be used to alter colour and properties of the melanin formed.
  • the oxidant enzyme converts DOPA to dopaquinone and subsequently to dopacharome .
  • dopachrome is converted to a variety of intermediates such as dihydroxyindole, 5,6 dihydroxyindole-2-carboxylic acid, indole-5 , 6-quinone and/or melanochrome .
  • the acidic proteins/peptides present in the reaction mixture assist in the polymerisation of these intermediates resulting in the formation of the soluble, protein-bound melanin of the present invention.
  • the invention also provides a soluble protein- and/or peptide-bound melanin obtainable by the process according to the first aspect of the present invention.
  • a sunscreen composition comprising:
  • the present invention also provides a synergistic skin lightening composition comprising:
  • the skin lightening caused by the composition of the invention is reversible and without any side effects.
  • Skin whitening agent may be chosen from niacin, niacinamide or a precursor thereof, extracts of placenta, hydroquinone and derivatives (eg. arbutin) , kojic acid, dicarboxylic acids (azelaic acid, sebacic acid) , represented by the formula
  • organic sunscreens such as 4- tertiary butyl-4 ' -methoxy dibenzoylmethane, available under the trade name PARSOL 1789 from Givaudan, and/
  • the sunscreen and skin lightening composition can include cosmetically compatible carriers, preservatives, emulsifiers, thickeners, perfume, colour, skin benefit materials such as moisturisers, emollients antiageing compounds and other skin benefit agents.
  • the vehicle which forms part of the cosmetic composition is cosmetically acceptable in that it will not harm the skin.
  • the vehicles that can be used in the compositions according to the invention can include powder absorbents, binders and carriers, and liquids such as emollients, propellants, solvents, humectants and thickeners, for example.
  • Moisturisers and humectants such as polyols, glycerol, cetyl alcohol, carbopol 934, ethoxylated castor oil, paraffin oils, lanolin and its derivatives, etc may also be present.
  • Silicone compounds such as silicone surfactants like DC3225C (Dow Corning) and/or silicone emollients, silicone oil (DC- 200 Ex-Dow Corning) can be used.
  • compositions according to the invention can be prepared for topical application to the skin in the form of conventional products such as lotions, creams, ointments and aerosol products.
  • the soluble melanin was prepared by reacting 5 ⁇ M of DL-DOPA and 0.45 ⁇ g of tyrosinase in a 0.125 M sodium acetate buffer pH 5.0, in a final volume of 1 ml .
  • the acidic protein Bovine serum albumin (BSA) with pi 4.6 and a molecular weight
  • the data presented in Table 1 shows that in presence of an acidic protein the level of soluble melanin formed is significantly increased over control.
  • the soluble melanin produced according to the invention is soluble in an aqueous solution at pH 2 to 11 and temperature 0°C to 50°C. It is protein bound, and of a very high molecular weight (100 - 200 Kda) . It can be filtered through a 0.22 ⁇ filter and remains in the soluble form when ultracentrifuged at 1,05,000 x g for 1 hour.
  • the soluble melanin is stable on acidification or alkalisation but gets precipitated on boiling. It can be lyophilised into a crystal form and redissolved in water. It varies in colour from golden brown to black and absorbs throughout the UV and visible wavelengths .
  • the melanin preparation was done as described in example 1 but using proteins with different pi to determine the effect of acidic protein on the formation of soluble melanin.
  • the proteins used are as described in Table 2. Table 2
  • This example illustrates a suncare cream incorporating the composition of the invention:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

A process for preparing protein- and/or peptide-bound melanin, which is soluble in an aqueous solution at pH 2 to 11 and temp 0 °C to 50 °C, comprising the steps of reacting dihydroxyphenylalanine with an oxidant enzyme in the presence of an acidic protein and/or peptide having a pI of 3-6. The soluble protein- and/or peptide-bound melanin of this invention is useful as a sunscreen and as a colouring and/or flavouring for food.

Description

SUNSCREEN COMPOSITION
The present invention relates to a process of producing melanin polymers in soluble form and to compositions including such polymers for providing sunscreen benefits by preventing the damaging effects of ultra-violet light on skin.
BACKGROUND AND PRIOR ART
The treatment of human skin damaged through exposure to ultra-violet (UV) light, i.e. photo-damage, has been subject to much research effort in recent years, particularly with the realisation that skin cancer and other skin disorders can arise where the exposure to sunlight is excessive. The sensitivity of the human skin to UV exposure is dependent on the amount of the pigment melanin present in the skin.
The purpose of a sunscreen is to block the excessive UV radiation from affecting the skin. Sunscreens act by deflecting and scattering the incident light that produces burning and tanning of the skin or by absorbing this light. To prevent darkening of existing melanin in the skin, the skin has to be protected broadly across the UV range of about 320-400 nm. It is known that careful selection of sunscreens can offer this protection to the skin and reduce the darkening and damaging effects of the radiation.
WO 96/25920 (Yale University) , describes the use of melanin polymers in cosmetic compositions for providing a substantive, natural appearing tan and to protect the skin from harmful effects of ultraviolet radiation. Since melanins absorb light throughout the ultraviolet and visible spectra, solubilised melanins are also be effective as glass or plastic tinting agents for eye glasses, contact lenses, car windows, house windows, office buildings etc. Apart from cosmetic benefits, soluble melanins can also be used as colouring agents in coffee, tea, soda, whiskey and other liquors .
WO 92/16189 (Yale University) , disclose compositions and methods for preparing soluble melanins stable at physiological pH and temperature. The method comprises reacting dopachrome and one or more enzymes derived from biological cells or tissues which have a pigmentary system. The melanin produced is soluble in an aqueous solution at a pH of at least 5 to 9 at a temperature of 0 to 100°C.
The commercial value of melanins that are soluble at physiological pH and temperature is very great . Soluble melanins occur in nature as isolated polymers or as bound to proteins. It is known that soluble melanin that is bound to protein has much wider scope as a sunscreen than the unbound melanin and will also be more stable and will not get degraded into toxic monomeric compounds.
It is the object of the present invention to provide a process for preparing solubilised forms of melanin bound to a peptide/protein with a pi in the range of 3 to 6. The melanin formed therein is soluble in an aqueous solution at pH 2 to 11 and temperature 0°C to 50°C. It is another object of the present invention to provide compositions comprising such melanin useful for providing sunscreen benefits by preventing the damaging effects of ultra-violet light on skin.
It is another object of the present invention to provide compositions comprising such melanin useful for colouring and or flavouring foodstuffs such as coffee, tea, soda and other beverages .
According to a first aspect of the present invention there is provided a process for preparing protein- and/or peptide- bound melanin, which is soluble in an aqueous solution at pH 2 to 11 and temperature 0°C to 50°C, comprising the steps of reacting dihydroxyphenylalanine with an oxidant enzyme in the presence of an acidic protein and/or peptide having a pi of 3-6.
The reaction mixture may optionally additionally comprise one or more of the following: Dihydroxyindole, 5,6 dihydroxyindole-2-carboxylic acid, dopachrome, indole-5,6- quinone and/or melanochrome.
Preferably the enzyme is a naturally occurring oxidant enzyme such as a tyrosinase. The enzyme source could be either mushroom or neurospora crassa or other natural sources .
The dihydroxyphenylalanine (DOPA) is preferably DL- or L- DOPA. The proteins used should preferably have a molecular weight of at least 45,000 Da and a pi of 3 to 6. Suitable proteins include Bovine Serum Albumin and Ovalbumin for example. The concentration of protein used may be 1 μM to ImM and is preferably 10-100 μM. The reaction mixture preferably contains DOPA, oxidant enzyme and the acidic protein/peptide in the ratio of 1 : 0.2-0.4 : 0.6-1.2.
Metal ions such as copper, zinc and iron may also be used to alter colour and properties of the melanin formed.
It is thought that the oxidant enzyme converts DOPA to dopaquinone and subsequently to dopacharome . At this stage, in the presence of oxygen and light, dopachrome is converted to a variety of intermediates such as dihydroxyindole, 5,6 dihydroxyindole-2-carboxylic acid, indole-5 , 6-quinone and/or melanochrome . The acidic proteins/peptides present in the reaction mixture assist in the polymerisation of these intermediates resulting in the formation of the soluble, protein-bound melanin of the present invention.
The invention also provides a soluble protein- and/or peptide-bound melanin obtainable by the process according to the first aspect of the present invention.
According to a further aspect of the present invention there is provided a sunscreen composition comprising:
(a) 0.1 to 10% by weight of the composition of the soluble, protein- and/or peptide-bound melanin of the present invention and;
(b) a cosmetically acceptable vehicle. The present invention also provides a synergistic skin lightening composition comprising:
(a) from 0.1 to 10 % by weight of the composition of a skin whitening agent and;
(b) 0.1 to 10% by weight of the composition of soluble, protein- and/or peptide-bound melanin.
The skin lightening caused by the composition of the invention is reversible and without any side effects.
Skin whitening agent may be chosen from niacin, niacinamide or a precursor thereof, extracts of placenta, hydroquinone and derivatives (eg. arbutin) , kojic acid, dicarboxylic acids (azelaic acid, sebacic acid) , represented by the formula
HOOC- (CxHy) -COOH where x=4 to 20 and y=6 to 40, ascorbic acid and derivatives thereof, hydroxy acids (lactic acid, glycolic acid, malic acid, tartaric acid etc) , ferulic acid, retinol and derivatives, polyamino acid sequence with an isoelectric point (pi) between 2 to 5.5, organic sunscreens such as 4- tertiary butyl-4 ' -methoxy dibenzoylmethane, available under the trade name PARSOL 1789 from Givaudan, and/or 2 -ethyl hexyl methoxy cinnamate, available under the trade name PARSOL MCX from Givaudan or other UV A and UV B sunscreens and any other known skin whitening compounds.
The sunscreen and skin lightening composition, according to the invention can include cosmetically compatible carriers, preservatives, emulsifiers, thickeners, perfume, colour, skin benefit materials such as moisturisers, emollients antiageing compounds and other skin benefit agents. The vehicle which forms part of the cosmetic composition is cosmetically acceptable in that it will not harm the skin. The vehicles that can be used in the compositions according to the invention can include powder absorbents, binders and carriers, and liquids such as emollients, propellants, solvents, humectants and thickeners, for example.
Moisturisers and humectants such as polyols, glycerol, cetyl alcohol, carbopol 934, ethoxylated castor oil, paraffin oils, lanolin and its derivatives, etc may also be present.
Silicone compounds such as silicone surfactants like DC3225C (Dow Corning) and/or silicone emollients, silicone oil (DC- 200 Ex-Dow Corning) can be used.
The compositions according to the invention can be prepared for topical application to the skin in the form of conventional products such as lotions, creams, ointments and aerosol products.
The invention will now be illustrated by way of Examples. The Examples are for illustration only and do not in any way restrict the scope of the invention. EXAMPLES
Example 1
Process for the preparation of soluble protein bound melanin
The soluble melanin was prepared by reacting 5μM of DL-DOPA and 0.45 μg of tyrosinase in a 0.125 M sodium acetate buffer pH 5.0, in a final volume of 1 ml . The acidic protein Bovine serum albumin (BSA) with pi 4.6 and a molecular weight
66,000 kD, at different concentrations (Table 1) was tested. The control sample was without the acidic protein. The samples were incubated for 12 hours at 25°C and then centrifuged at 16,000 x g for 10 minutes to pellet the melanin. The absorbance of the supernatant was measured at 500 nm (A 500 nm) to determine the level of soluble or non- pelletable melanin. The pellet was washed and sonicated in lml distilled water and the absorbance measured at 500 nm to determine the level of pelletable melanin. The melanin prepared was also analysed for its properties.
Table 1
Figure imgf000009_0001
The data presented in Table 1 shows that in presence of an acidic protein the level of soluble melanin formed is significantly increased over control. The soluble melanin produced according to the invention is soluble in an aqueous solution at pH 2 to 11 and temperature 0°C to 50°C. It is protein bound, and of a very high molecular weight (100 - 200 Kda) . It can be filtered through a 0.22 μ filter and remains in the soluble form when ultracentrifuged at 1,05,000 x g for 1 hour. The soluble melanin is stable on acidification or alkalisation but gets precipitated on boiling. It can be lyophilised into a crystal form and redissolved in water. It varies in colour from golden brown to black and absorbs throughout the UV and visible wavelengths .
Example 2
Effect of different proteins on the formation of soluble protein bound melanin
The melanin preparation was done as described in example 1 but using proteins with different pi to determine the effect of acidic protein on the formation of soluble melanin. The proteins used are as described in Table 2. Table 2
Figure imgf000011_0001
The data presented in Table 2 shows that the increase in the soluble melanin is due to the presence of an acidic protein and there is no corresponding increase when a basic protein (pi 8.0) was present.
Example 3
Skin lightening composition according to the invention
The invention will now be illustrated by reference to the following example of a cosmetic cream.
Figure imgf000012_0001
Example 4
Sunscreen Composition
This example illustrates a suncare cream incorporating the composition of the invention:
Figure imgf000013_0001

Claims

A process for preparing protein- and/or peptide- bound melanin, which is soluble in an aqueous solution at pH 2 to 11 and temp 0°C to 50°C, comprising the steps of reacting dihydroxyphenylalanine with an oxidant enzyme in the presence of an acidic protein and/or peptide having a pi of 3-6.
A process according to claim 1 wherein the enzyme is a tyrosinase .
3. A process according to claim 2 wherein the source of tyrosinase is neurospora crassa .
4. A process according to any preceding claim wherein the protein and/or peptide has a molecular weight of at least 45,000 Da.
5. A process according to any preceding claim wherein the concentration of protein/peptide in the reaction mixture is lμM to 1 mM.
6. A process according to any preceding claim wherein the ratio of dihydroxyphenylalanine to oxidant enzyme to acidic protein/peptide is 1: 0.2-0.4: 0.6-1.2.
7. A process according to any preceding claim wherein the reaction mixture also comprises copper, zinc or iron ions .
8. A protein- and/or peptide-bound melanin, which is soluble in an aqueous solution at pH 2 to 11 and temp 0°C to 50°C, obtainable by the process of claims 1-7.
9. A sunscreen composition comprising:
(a) 0.1 to 10% by weight of the composition of the soluble protein- and/or peptide-bound melanin of claim 8 and
(b) a cosmetically acceptable vehicle.
10. A colouring and/or flavouring composition for food stuffs comprising the soluble protein-and/or peptide-bound melanin of claim 8.
11. Use of the soluble protein-and/or peptide-bound melanin of claim 8 as a sunscreen.
12. Use of the soluble protein-and/or peptide-bound melanin of claim 8 as a food colouring and/or flavouring.
13. A skin lightening composition comprising:
(a) from 0.1 to 10% by weight of the composition of a skin whitening agent .
(b) 0.1 to 10% by weight of the composition of soluble protein and/or peptide-bound melanin.
PCT/EP2000/001645 1999-03-17 2000-02-29 Sunscreen composition WO2000055348A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU29160/00A AU2916000A (en) 1999-03-17 2000-02-29 Sunscreen composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN193/BOM/99 1999-03-17
IN193BO1999 IN191336B (en) 1999-03-17 1999-03-17
GB9910274.1 1999-05-04
GBGB9910274.1A GB9910274D0 (en) 1999-05-04 1999-05-04 Sunscreen composition

Publications (1)

Publication Number Publication Date
WO2000055348A1 true WO2000055348A1 (en) 2000-09-21

Family

ID=26315506

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/001645 WO2000055348A1 (en) 1999-03-17 2000-02-29 Sunscreen composition

Country Status (2)

Country Link
AU (1) AU2916000A (en)
WO (1) WO2000055348A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515773A (en) * 1983-07-05 1985-05-07 Repligen Corporation Skin tanning composition and method
EP0455175A2 (en) * 1990-05-02 1991-11-06 Taenaka Mining Co. Ltd. Modified melanin
WO1992000373A1 (en) * 1990-06-29 1992-01-09 Biosource Genetics Corporation Melanin production by transformed microorganisms
WO1992016189A1 (en) * 1990-10-25 1992-10-01 Yale University Soluble melanin
US5216116A (en) * 1990-05-18 1993-06-01 Yale University Soluble melanin
WO1995013386A2 (en) * 1993-11-12 1995-05-18 Biosource Technologies Incorporated Tyrosinase-activator protein fusion enzyme
WO1996025920A1 (en) * 1995-02-23 1996-08-29 Yale University Cosmetic melanins

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515773A (en) * 1983-07-05 1985-05-07 Repligen Corporation Skin tanning composition and method
EP0455175A2 (en) * 1990-05-02 1991-11-06 Taenaka Mining Co. Ltd. Modified melanin
US5216116A (en) * 1990-05-18 1993-06-01 Yale University Soluble melanin
WO1992000373A1 (en) * 1990-06-29 1992-01-09 Biosource Genetics Corporation Melanin production by transformed microorganisms
WO1992016189A1 (en) * 1990-10-25 1992-10-01 Yale University Soluble melanin
WO1995013386A2 (en) * 1993-11-12 1995-05-18 Biosource Technologies Incorporated Tyrosinase-activator protein fusion enzyme
WO1996025920A1 (en) * 1995-02-23 1996-08-29 Yale University Cosmetic melanins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ITO S ET AL: "CHARACTERIZATION OF MELANOGENESIS IN MOUSE AND GUINEA-PIG HAIR BY CHEMICAL ANALYSIS OF MELANINS AND OF FREE AND BOUND DOPA AND 5-S CYSTEINYL DOPA", JOURNAL OF INVESTIGATIVE DERMATOLOGY 1984, vol. 83, no. 1, 1984, pages 12 - 14, XP000914744, ISSN: 0022-202X *
UEMURA T ET AL: "NADPH DEPENDENT MELANIN PIGMENT FORMATION FROM 5 HYDROXY INDOLEALKYLAMINES BY HEPATIC AND CEREBRAL MICROSOMES", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 1980, vol. 93, no. 4, 1980, pages 1074 - 1081, XP000914739, ISSN: 0006-291X *

Also Published As

Publication number Publication date
AU2916000A (en) 2000-10-04

Similar Documents

Publication Publication Date Title
AU702553B2 (en) Cosmetic melanins
JPH07509012A (en) synthetic melanin
Levy Dihydroxyacetone-containing sunless or self-tanning lotions
KR101832288B1 (en) Method of preparing green tea extract by using magma seawater, carbonated water, or bedrock water, and functional cosmetic composition comprising the same
WO1996025920A9 (en) Cosmetic melanins
JP2013522198A (en) Compounds, compositions and methods for protecting skin from high energy visible light
EP1596819A1 (en) Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor
EP1049450B1 (en) Skin and hair darkening composition
JP2019502745A (en) A composition that brightens the skin, provides protection from sunlight and enables vitamin D production
KR100905388B1 (en) Leaf extract of fragaria ananassa duchesne complex having skin whitening activity containing ellagic acid
EP1401504B1 (en) Uv-screening peptide-flavonoid conjugates
KR101475505B1 (en) A whitening cosmetic composition containing Hizikia fusiformis extract
US6315988B1 (en) Process for preparing protein-bound melanin and/or peptide bound melanin, and products thereof
Haywood et al. Synthetic melanin is a model for soluble natural eumelanin in UVA-photosensitised superoxide production
EP1465589B1 (en) Skin-lightening composition
EP0585018A1 (en) Cosmetic composition for coloring hair and skin and for UV-protection
WO2000055348A1 (en) Sunscreen composition
WO1995009629A1 (en) Synthetic melanin
KR0177018B1 (en) Skin whitening cosmetic composition
CN104983602A (en) Whitening agent combining water-soluble glabridin and endothelin antagonist
KR101921903B1 (en) Composition for antioxidation or whitening containing 21-O-angeloyltheasapogenol E3 from green tea seed
KR101963344B1 (en) Composition for blocking ultraviolet comprising aromatic amino acid or phenolic polymer as effective component
JPH07508554A (en) Process for producing melanin pigments with small particle size and their use in cosmetics
JP3332253B2 (en) UV absorbing pigment
US20240000694A1 (en) Methods and Materials for Matching Chemistry of Individuals and Human Melanin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase